Theresa Hegmann

MedicineHealth ProfessionsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18–45 years of age”.

A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18–45 years of age

Vaccine(2025)10.1016/j.vaccine.2025.126991

N/A

0.226DataRank · unranked

3 citations

Emmanuel B. Walter, Michael J. Smith, James Campbell, Hana M. El Sahly, Jennifer A. Whitaker +20 more

A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf571

N/A

0DataRank · unranked

1 citations

Theresa Hegmann, Hana M. El Sahly, Evan J. Anderson, DMID 15-0038 Study Group, Nancy B. Wagner +14 more